CVB vs EMD

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

CVB

CURVEBEAM FPO [CVB]

51MEDIUM

EMD

EMYRIAL FPO [EMD]

51MEDIUM

Score Breakdown

CVB EMD
Technical
38
55
Catalyst
52
52
Sentiment
50
50
Fundamental
47
65
Momentum
49
76
Risk Gate
42
45

Key Metrics

CVB Metric EMD
$25.3MMarket Cap$35.5M
376KAvg Volume (20d)994K
+0.2%Short InterestN/A
$0.17552-Week High$0.078
$0.05252-Week Low$0.021
+0.0%Daily Change+18.9%
$0.053Entry Price$0.044
-41.8%ROE-58.6%
-133.1%Profit Margin-198.5%

Active Signals

CVB Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 3.6% over the last 5 days
●Lagging the Small Ords index — relative strength of 0.86, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.6 quarters)
●Low P/S ratio (2.1x)
●Piotroski F-Score weak (2/9, low-confidence approx)

EMD Signals

●On a tear — up 10.0% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (11 quarters)
●Strong revenue growth (+136%)
●Small-cap ($20-100M)
●Deeply negative margins (-199%)
●Not enough chatter to gauge sentiment — defaulting to neutral
●Sentiment is mixed — no strong consensus either way

Ask Scout AI to compare CVB and EMD in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CVB Full Analysis → EMD Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).